← Browse by Condition
Medical Condition

unresectable urothelial carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06439836 Phase 1
Recruiting

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

Enrollment
27 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →